LF and HF, low frequency and high frequency components of power index
[] The most recent 3-month trial from 2025 confirmed the efficacy of 1.5 mg once-a-week dulaglutide in patients with T2DM and MASLD with a liver fat content decreased by a mean of 3.71%, with greater reductions in those with higher initial fat content (0.37% vs
Its ability to help people lose weight by targeting multiple receptors sets it apart from other treatments, offering better results for many people
consumer-facing aggregator with citations to clinical trial data
For a disulfide-containing synthetic peptide, a stronger analytical package may require orthogonal identity and purity methods, evidence supporting disulfide configuration, impurity profiling, assay or net peptide content, water and counterion determination, residual-solvent testing, and stability-indicating methods